The Apex Times
Above the Noise
Business Wire
BusinessYahoo Finance flags a new, under-discussed complication for Intel tied to Elon MuskThe Apex TimesBusinessTesla pushes into heavy-duty trucking with a first Megacharger site, while markets weigh a separate driver of engagement: tokenized stock tradingThe Apex TimesBusinessMicrosoft’s AI push may be keeping its valuation below other big tech peers, market commentator saysThe Apex TimesBusinessCorn’s rebound enters the spotlight, and Jim Cramer ties the question back to DeereThe Apex TimesBusinessBroadcom’s $42 Billion “Loan” to Anthropic Raises Questions About AI Financing and Future Equity StakesThe Apex TimesBusinessJim Cramer Points to Home Depot as Bond-Market Relief Could Lift Consumer StocksThe Apex TimesBusinessA popular market note argues Palantir’s valuation is an outlier and could face a reset by 2028The Apex TimesBusinessNvidia’s shares set records again, but some analysts question how much upside is already priced inThe Apex TimesBusinessVisa stock debate turns on whether larger client rebates justify the valuationThe Apex TimesBusinessBig Bank Earnings and Key Inflation and Housing Data Set the Tone for Markets This WeekThe Apex TimesBusinessYahoo Finance revisits Buffett dividend winners, highlighting American Express and Coca-Cola alongside Bank of America and ChevronThe Apex TimesBusinessCoca-Cola Consolidated declares fourth-quarter dividend of $0.25 per shareThe Apex TimesBusinessYahoo Finance flags a new, under-discussed complication for Intel tied to Elon MuskThe Apex TimesBusinessTesla pushes into heavy-duty trucking with a first Megacharger site, while markets weigh a separate driver of engagement: tokenized stock tradingThe Apex TimesBusinessMicrosoft’s AI push may be keeping its valuation below other big tech peers, market commentator saysThe Apex TimesBusinessCorn’s rebound enters the spotlight, and Jim Cramer ties the question back to DeereThe Apex TimesBusinessBroadcom’s $42 Billion “Loan” to Anthropic Raises Questions About AI Financing and Future Equity StakesThe Apex TimesBusinessJim Cramer Points to Home Depot as Bond-Market Relief Could Lift Consumer StocksThe Apex TimesBusinessA popular market note argues Palantir’s valuation is an outlier and could face a reset by 2028The Apex TimesBusinessNvidia’s shares set records again, but some analysts question how much upside is already priced inThe Apex TimesBusinessVisa stock debate turns on whether larger client rebates justify the valuationThe Apex TimesBusinessBig Bank Earnings and Key Inflation and Housing Data Set the Tone for Markets This WeekThe Apex TimesBusinessYahoo Finance revisits Buffett dividend winners, highlighting American Express and Coca-Cola alongside Bank of America and ChevronThe Apex TimesBusinessCoca-Cola Consolidated declares fourth-quarter dividend of $0.25 per shareThe Apex TimesBusinessYahoo Finance flags a new, under-discussed complication for Intel tied to Elon MuskThe Apex TimesBusinessTesla pushes into heavy-duty trucking with a first Megacharger site, while markets weigh a separate driver of engagement: tokenized stock tradingThe Apex TimesBusinessMicrosoft’s AI push may be keeping its valuation below other big tech peers, market commentator saysThe Apex TimesBusinessCorn’s rebound enters the spotlight, and Jim Cramer ties the question back to DeereThe Apex TimesBusinessBroadcom’s $42 Billion “Loan” to Anthropic Raises Questions About AI Financing and Future Equity StakesThe Apex TimesBusinessJim Cramer Points to Home Depot as Bond-Market Relief Could Lift Consumer StocksThe Apex TimesBusinessA popular market note argues Palantir’s valuation is an outlier and could face a reset by 2028The Apex TimesBusinessNvidia’s shares set records again, but some analysts question how much upside is already priced inThe Apex TimesBusinessVisa stock debate turns on whether larger client rebates justify the valuationThe Apex TimesBusinessBig Bank Earnings and Key Inflation and Housing Data Set the Tone for Markets This WeekThe Apex TimesBusinessYahoo Finance revisits Buffett dividend winners, highlighting American Express and Coca-Cola alongside Bank of America and ChevronThe Apex TimesBusinessCoca-Cola Consolidated declares fourth-quarter dividend of $0.25 per shareThe Apex TimesBusinessYahoo Finance flags a new, under-discussed complication for Intel tied to Elon MuskThe Apex TimesBusinessTesla pushes into heavy-duty trucking with a first Megacharger site, while markets weigh a separate driver of engagement: tokenized stock tradingThe Apex TimesBusinessMicrosoft’s AI push may be keeping its valuation below other big tech peers, market commentator saysThe Apex TimesBusinessCorn’s rebound enters the spotlight, and Jim Cramer ties the question back to DeereThe Apex TimesBusinessBroadcom’s $42 Billion “Loan” to Anthropic Raises Questions About AI Financing and Future Equity StakesThe Apex TimesBusinessJim Cramer Points to Home Depot as Bond-Market Relief Could Lift Consumer StocksThe Apex TimesBusinessA popular market note argues Palantir’s valuation is an outlier and could face a reset by 2028The Apex TimesBusinessNvidia’s shares set records again, but some analysts question how much upside is already priced inThe Apex TimesBusinessVisa stock debate turns on whether larger client rebates justify the valuationThe Apex TimesBusinessBig Bank Earnings and Key Inflation and Housing Data Set the Tone for Markets This WeekThe Apex TimesBusinessYahoo Finance revisits Buffett dividend winners, highlighting American Express and Coca-Cola alongside Bank of America and ChevronThe Apex TimesBusinessCoca-Cola Consolidated declares fourth-quarter dividend of $0.25 per shareThe Apex Times
Back to front
Johnson & Johnson set to report third-quarter results on Oct. 13
The Apex Times

THE APEX TIMES

Business/The Apex Times/Oct 11, 3:50 PM EDT

Johnson & Johnson set to report third-quarter results on Oct. 13

The healthcare conglomerate will release its next earnings update this month, a key checkpoint for investors tracking demand across its pharmaceuticals and medical-technology businesses.

By The Apex Times Newsroom2 min readAI-assisted Apex article

Johnson & Johnson is scheduled to report its third-quarter results on Oct. 13, according to a market calendar update published by Yahoo Finance and syndicated by Barchart. For investors, the date matters because quarterly earnings often drive near-term shifts in expectations for revenue growth, margins, and company guidance.

The announcement comes as traders and analysts prepare for a fresh set of disclosures on how J&J’s performance changed over the quarter. Earnings reports typically include results for the period, commentary on business trends, and any updates the company chooses to provide on its outlook.

Johnson & Johnson, which trades on the New York Stock Exchange under the ticker JNJ, operates across multiple healthcare segments. Those include prescription medicines and medical devices, areas where quarterly results can be influenced by product demand, manufacturing and supply conditions, and market pricing dynamics.

In the market, earnings dates can also affect positioning. Investors often adjust exposure ahead of a report due to the potential for surprises, including changes in revenue trajectories, operating expense patterns, or updated assumptions used in forecasts.

While the calendar item confirms the Oct. 13 reporting date for third-quarter results, it does not provide additional detail on timing of the release, the metrics investors can expect, or whether Johnson & Johnson will offer specific guidance alongside the financial statements.

That means investors will need to wait for the company’s own earnings materials to learn what management highlights and how it frames the quarter. The post does not specify any figures or outcomes, so the substance of the report remains undisclosed ahead of the release date.

For the broader healthcare sector, J&J’s earnings can serve as a read-through for how large diversified companies are faring amid competitive pressures and shifting customer demand across care settings. Even without new information in the calendar notice, big-cap earnings can influence sentiment across peers.

Why It Matters

  • Earnings dates often concentrate trading activity and can lead to sharp market moves once results are released.
  • Investors will use the third-quarter update to recalibrate expectations for J&J’s revenue trajectory and business momentum.
  • Because Johnson & Johnson spans pharmaceuticals and medical technology, the quarter can influence sentiment toward multiple healthcare sub-sectors.
  • The lack of pre-release detail means the market will rely on the company’s formal earnings materials for metrics, commentary, and any outlook.

Sources

Key Facts

  • Johnson & Johnson plans to report its third-quarter results on Oct. 13.
  • The scheduling update was published by Yahoo Finance and syndicated by Barchart.
  • The company is listed on the NYSE under ticker JNJ.
  • The calendar item confirms the reporting date but does not include financial figures or further operational detail.

Healthcare Related

Oct 11, 7:31 AM EDT
The Apex Times

Moderna shares face modest valuation lift after analyst fair-value update

A fresh round of analyst modeling revised Moderna’s per-share fair value slightly higher, with the estimate moving from $119.56 to $122.67, according to a market report citing updated assumptions tied to the company’s cancer-vaccine outlook.

Moderna shares face modest valuation lift after analyst fair-value update
The Apex Times
Johnson & Johnson set to report third-quarter results on Oct. 13 | The Apex Times